Leukemia Cell Surface Antigen Modulation Induced By Dual CD19/CD20 Chimeric Antigen Receptor (CAR)-T Cells

被引：0
|
作者：
Schneider, Dina [1 ]
Xiong, Ying [1 ]
Wu, Darong [1 ]
Nolle, Volker [2 ]
Schmitz, Sarah [2 ]
Kaiser, Andrew [2 ]
Dropulic, Boro [3 ]
Orentas, Rimas [3 ]
机构：
[1] Miltenyi Biotec Co, Lentigen Technol Inc, Translat Res & Dev, Gaithersburg, MD USA
[2] Miltenyi Biotec GmbH, Bergisch Gladbach, Germany
[3] Miltenyi Biotec Co, Lentigen Technol Inc, Gaithersburg, MD USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2017年 / 23卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
273
引用
收藏
页码：S209 / S210
页数：2
相关论文
共 50 条
  • [41] CD19 chimeric antigen receptor-T cells in B-cell leukemia and lymphoma: current status and perspectives
    Mohty, Mohamad
    Gautier, Jordan
    Malard, Florent
    Aljurf, Mahmoud
    Bazarbachi, Ali
    Chabannon, Christian
    Kharfan-Dabaja, Mohamed A.
    Savani, Bipin N.
    Huang, He
    Kenderian, Saad
    Nagler, Arnon
    Perales, Miguel-Angel
    LEUKEMIA, 2019, 33 (12) : 2767 - 2778
  • [42] Targeting of CD19 By Tafasitamab Does Not Impair CD19 Directed Chimeric Antigen Receptor T Cell Activity in Vitro
    Horvei, Paulina
    Sakemura, Reona
    Cox, Michelle J.
    Ruff, Michael W.
    Hefazi, Mehrdad
    Tapper, Erin E.
    Schick, Kendall J.
    Roman, Claudia Manriquez
    Kuhlmann, Charles J.
    Schanzer, Juergen
    Endell, Jan
    Nowakowski, Grzegorz
    Kay, Neil E.
    Kenderian, Saad S.
    BLOOD, 2019, 134
  • [43] CD19 Chimeric Antigen Receptor T Cell Therapy for the Treatment of B Cell Lineage Acute Lymphoblastic Leukemia
    Chen, Runzhe
    Song, Xiao-Tong
    Chen, Baoan
    DISCOVERY MEDICINE, 2015, 20 (110) : 185 - 190
  • [44] Retargeting CD19 Chimeric Antigen Receptor T Cells via Engineered CD19-Fusion Proteins
    Klesmith, Justin R.
    Su, Lihe
    Wu, Lan
    Schrack, Ian A.
    Dufort, Fay J.
    Birt, Alyssa
    Ambrose, Christine
    Hackel, Benjamin J.
    Lobb, Roy R.
    Rennert, Paul D.
    MOLECULAR PHARMACEUTICS, 2019, 16 (08) : 3544 - 3558
  • [45] Application of Novel T Cell Immunotherapeutics to Drive Antigen-Specific Activation, Expansion, and Differentiation of CD19 Chimeric Antigen Receptor T Cells (CAR T-cells)
    Rabin, Moriah
    Li, Mengyan
    Garforth, Scott
    Marino, Jacqueline
    Zheng, Jian Hua
    O'Connor, Kaitlyn E.
    Almo, Steven C.
    Goldstein, Harris
    BLOOD, 2020, 136
  • [46] Efficacy and safety of CD19 CAR T constructed with a new anti-CD19 chimeric antigen receptor in relapsed or refractory acute lymphoblastic leukemia
    Gu, Runxia
    Liu, Fang
    Zou, Dehui
    Xu, Yingxi
    Lu, Yang
    Liu, Bingcheng
    Liu, Wei
    Chen, Xiaojuan
    Liu, Kaiqi
    Guo, Ye
    Gong, Xiaoyuan
    Lv, Rui
    Chen, Xia
    Zhou, Chunlin
    Zhong, Mengjun
    Wang, Huijun
    Wei, Hui
    Mi, Yingchang
    Qiu, Lugui
    Lv, Lulu
    Wang, Min
    Wang, Ying
    Zhu, Xiaofan
    Wang, Jianxiang
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [47] Identification of Functional Determinants of Response and Resistance to CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy of Chronic Lymphocytic Leukemia
    Fraietta, Joseph A.
    Lacey, Simon F.
    Orlando, Elena
    Pruteanu, Julian
    Gohil, Mercy
    Wang, Yan
    Boesteanu, Alina
    OConnor, Roddy
    Ambrose, David E.
    Hwang, Wei-Ting
    Wilcox, Nicholas
    Bedoya, Felipe
    Dorfmeier, Corin
    Chen, Fang
    Parakandi, Harit
    Gupta, Minnal
    Pequignot, Edward
    Johnson, F. Brad
    Kulikovskaya, Irina
    Liu, Li
    Lundh, Stefan M.
    Xu, Jun
    Davis, Megan M.
    Young, Regina M.
    Levine, Bruce L.
    Siegel, Don L.
    Huang, Alexander
    Wherry, E. John
    Zhou, Jing
    Paczkowski, Patrick
    Mackay, Sean
    Brogdon, Jennifer
    Bitter, Hans
    Porter, David L.
    June, Carl H.
    Melenhorst, J. Joseph
    BLOOD, 2017, 130
  • [48] Efficacy and safety of CD19 CAR T constructed with a new anti-CD19 chimeric antigen receptor in relapsed or refractory acute lymphoblastic leukemia
    Runxia Gu
    Fang Liu
    Dehui Zou
    Yingxi Xu
    Yang Lu
    Bingcheng Liu
    Wei Liu
    Xiaojuan Chen
    Kaiqi Liu
    Ye Guo
    Xiaoyuan Gong
    Rui Lv
    Xia Chen
    Chunlin Zhou
    Mengjun Zhong
    Huijun Wang
    Hui Wei
    Yingchang Mi
    Lugui Qiu
    Lulu Lv
    Min Wang
    Ying Wang
    Xiaofan Zhu
    Jianxiang Wang
    Journal of Hematology & Oncology, 13
  • [49] Efficacy and Safety of Chimeric Antigen Receptor T Cells Targeting CD19 in Autoimmune Diseases
    Nicoletti, Simon
    HEMATOLOGIE, 2024, 30 (02): : 96 - 98
  • [50] CD19 chimeric antigen receptor-T cell therapy in murine immune thrombocytopenia
    Han, Fengjiao
    Jiang, Zhengqi
    Guo, Qiuyu
    Li, Yucan
    Li, Chaoyang
    Liang, Xiaohong
    Han, Lin
    Gallant, Reid C.
    Hou, Ming
    Peng, Jun
    Xu, Miao
    BRITISH JOURNAL OF HAEMATOLOGY, 2025,
12345